Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul;39(7):2158-65.
doi: 10.1161/STROKEAHA.107.507251. Epub 2008 May 1.

Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts

Rob P W Rouhl  1 , Robert J van Oostenbrugge, Jan Damoiseaux, Jan-Willem Cohen Tervaert, Jan Lodder
Affiliations

Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts

Rob P W Rouhl et al. Stroke. 2008 Jul.

Abstract

Background and purpose: Stroke is the leading cause of disability in the Western world; however, few therapies are at hand to decrease this burden.

Summary of review: Endothelial progenitor cells (EPCs) have been introduced in cardiovascular medicine as factotums. EPCs can repair damaged endothelium and attenuate the development and progression of atherosclerosis. Also, EPCs can form new vessels in ischemic areas and thus promote recovery after ischemic events. In stroke, however, EPC research is limited. In our overview, we provide background information on EPC use as a risk marker and as a potential therapeutic agent.

Conclusions: In our opinion, the lack of EPC studies in stroke should instigate vascular neurologists to participate in EPC research, as EPCs could also change pathophysiological concepts and improve clinical treatments in vascular neurology.

PubMed Disclaimer

Publication types